Ashraf Daoud – General Manager, AbbVie Saudi Arabia
Ashraf Daoud, General Manager for AbbVie in Saudi Arabia, highlights how the affiliate has harnessed Allergan’s portfolio to become a top five…
Demet Russ – Managing Director, Janssen Turkey
Janssen’s Managing Director for Turkey, Demet Russ, discusses her return to the country after 25 years abroad, having worked for Johnson &…
Dimitri Livadas – President & General Manager, Lilly…
Lilly Saudi Arabia’s Dimitri Livadas shares some of the misconceptions he had before moving to the Kingdom a couple of years ago, highlights the…
Mohamed Nasser – General Manager, Amgen Middle East &…
Amgen’s Middle East and Africa General Manager Mohamed Nasser discusses the company’s approach to the region; the opportunities in the Saudi…
Michael Hübner – New Venture Lead, Johnson & Johnson…
Johnson & Johnson Innovation focuses on accelerating all stages of innovation worldwide, forming collaborations between entrepreneurs and the…
Georg Schroeckenfuchs – President MEA and Head Gulf &…
Georg Schroeckenfuchs, Novartis’ president MEA and head of its Gulf and Saudi Country Group, explains how the company’s objectives are aligned…
Philipp Haas – Chairman of BOD & CEO, DEVA
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp…
Dun Yang – President & CEO, Anticancer Bioscience
Anticancer Bioscience is an exciting international precision oncology company, applying synthetic lethal approaches to develop targeted cancer…
Stefan Berg – General Manager, Pharmaplan AG Switzerland
Stefan Berg, general manager of Pharmaplan, one of the leading pharma engineering partners in Europe, outlines the key trends in this area, including…
Annie Tan – General Manager, Singapore, Thailand &…
Annie Tan highlights the strategy she laid out to navigate the BMS Singapore, Thailand and Malaysia affiliates through the COVID-19 pandemic; the…
Christiane von der Eltz – Country Speaker, Merck…
Merck Switzerland’s Christiane von der Eltz highlights the German firm’s recent big investments in Switzerland and how it forms a key part of…
Michael Bauer – CEO & Board Member, Cellestia
Dr Michael Bauer, a Novartis early development veteran, now serves as CEO of Basel-based Cellestia. Here, Bauer explains why Cellestia’s unique…